Incannex Healthcare Inc.

IXHL Healthcare Drug Manufacturers Specialty & Generic

Incannex Healthcare Inc.’s revenue for fiscal 2025 (year ended June 2025) was $86,000.00, up 616.7% from fiscal 2024. In the quarter to June 2026, revenue fell 92.3%, EPS grew 99.0% and free cash flow grew 327.7%, each against the same quarter a year earlier.

2.82 0.06 −2.08%
Market cap
$36.1M
P/E
0.0×
Fwd P/E
−2.4×
Dividend yield
—
F-score
3/9
Altman Z
−13.23
Beneish M
−5.82
Dividend safety
n/a

Incannex Healthcare Inc. (IXHL) P/E ratio

Alert me on P/E ratio

Incannex Healthcare Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2018 0.0× —
FY2017 0.0× —

Quarterly newest first

Period P/E ratio Change
Dec 2024 0.0× —
Sep 2024 0.0× —
Jun 2021 0.0× —
Dec 2020 0.0× —
2 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
SCYX SCYNEXIS, Inc. compare n/m
TXMD TherapeuticsMD, Inc. compare n/m
IXHL Incannex Healthcare Inc. n/m
CPHI China Pharma Holdings, Inc. compare n/m
RMTI Rockwell Medical, Inc. compare n/m
TLPH Talphera, Inc. compare n/m
SHPH Shuttle Pharmaceuticals Holdings, Inc. compare 0.2×
INCR InterCure Ltd. compare 8.8×
ZYBT Zhengye Biotechnology Holding Limited compare —
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on IXHL